|
TTRX Turn Therapeutics Inc 2023016 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-970,972.00 |
| Balance Sheet |
|
Current Assets
|
$11,452,842.00 |
|
Assets
|
$18,644,136.00 |
|
Current Liabilities
|
$5,130,522.00 |
|
Liabilities
|
$12,526,588.00 |
|
Equity
|
$6,117,548.00 |
|
Shares Out
|
29788040.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,632,807.00 |
|
Investing Cash Flow
|
$-12,227.00 |
| Market Analysis |
Market Cap
|
$245,751,330.00 |
|
Price
|
$8.43 |
|
BVPS
|
0.21 |
|
PB
|
39.29 |
|
EPS
|
-0.03 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:35 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:32 |
|
| Apr |
May |
Jun |
| 2026-03-31 |
-0.12 |
|
|
2026-05-11 |
-0.03 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TTRX documents filed with the SEC.
TTRX Filings
Clear
